Literature DB >> 17687244

Update: Influenza activity--United States and worldwide, 2006-07 season, and composition of the 2007-08 influenza vaccine.

.   

Abstract

During the 2006-07 season, influenza activity peaked in mid-February in the United States and was associated with less mortality and lower rates of pediatric hospitalizations than during the previous three seasons. In the United States, influenza A (H1) viruses predominated overall, but influenza A (H3) viruses were isolated more frequently than influenza A (H1) viruses late in the season. Although influenza A (H1), A (H3), and B viruses cocirculated worldwide, influenza A (H3) viruses were the most commonly reported type in Europe and Asia. Sporadic cases of avian influenza A (H5N1) virus infections associated with severe illness or death were reported among humans in Cambodia, China, Egypt, Indonesia, Laos, Nigeria, and Viet Nam. This report summarizes influenza activity in the United States and worldwide during the 2006-07 influenza season (October 1, 2006-May 19, 2007) and describes the composition of the 2007-08 influenza vaccine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17687244

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  16 in total

1.  Controlling Time-Dependent Confounding by Health Status and Frailty: Restriction Versus Statistical Adjustment.

Authors:  Leah J McGrath; Alan R Ellis; M Alan Brookhart
Journal:  Am J Epidemiol       Date:  2015-04-12       Impact factor: 4.897

2.  Seasonal influenza morbidity estimates obtained from telephone surveys, 2007.

Authors:  Laurie Kamimoto; Gary L Euler; Peng-Jun Lu; Arthur Reingold; James Hadler; Ken Gershman; Monica Farley; Pauline Terebuh; Patricia Ryan; Ruth Lynfield; Bernadette Albanese; Ann Thomas; Allen S Craig; William Schaffner; Lyn Finelli; Joseph Bresee; James A Singleton
Journal:  Am J Public Health       Date:  2012-12-13       Impact factor: 9.308

Review 3.  The burden of influenza B: a structured literature review.

Authors:  W Paul Glezen; Jordana K Schmier; Carrie M Kuehn; Kellie J Ryan; John Oxford
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

4.  Statement on Seasonal Influenza Vaccine for 2012-2013: Appendix I: New Evidence Review for Children 24 to 59 Months of Age: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2012-08-01

5.  The interaction of influenza H5N1 viral hemagglutinin with sialic acid receptors leads to the activation of human γδ T cells.

Authors:  Yanlai Lu; Zhen Li; Chi Ma; Hao Wang; Jing Zheng; Lianxian Cui; Wei He
Journal:  Cell Mol Immunol       Date:  2013-08-05       Impact factor: 11.530

6.  Influenza in older adults: impact of vaccination of school children.

Authors:  H Keipp Talbot; Katherine A Poehling; John V Williams; Yuwei Zhu; Qingxia Chen; Paul McNabb; Kathryn M Edwards; Marie R Griffin
Journal:  Vaccine       Date:  2009-01-31       Impact factor: 3.641

7.  Do people taking flu vaccines need them the most?

Authors:  Qian Gu; Neeraj Sood
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

8.  Household responses to school closure resulting from outbreak of influenza B, North Carolina.

Authors:  April J Johnson; Zack S Moore; Paul J Edelson; Lynda Kinnane; Megan Davies; David K Shay; Amanda Balish; Meg McCarron; Lenee Blanton; Lyn Finelli; Francisco Averhoff; Joseph Bresee; Jeffrey Engel; Anthony Fiore
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

9.  Novel framework for assessing epidemiologic effects of influenza epidemics and pandemics.

Authors:  Carrie Reed; Matthew Biggerstaff; Lyn Finelli; Lisa M Koonin; Denise Beauvais; Amra Uzicanin; Andrew Plummer; Joe Bresee; Stephen C Redd; Daniel B Jernigan
Journal:  Emerg Infect Dis       Date:  2013-01       Impact factor: 6.883

10.  Immunity toward H1N1 influenza hemagglutinin of historical and contemporary strains suggests protection and vaccine failure.

Authors:  Stephen S H Huang; Zhen Lin; David Banner; Alberto J León; Stéphane G Paquette; Barry Rubin; Salvatore Rubino; Yi Guan; David J Kelvin; Alyson A Kelvin
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.